- Securities Registration: Employee Benefit Plan (S-8)
October 16 2009 - 4:39PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.
20549
FORM S-8
REGISTRATION
STATEMENT
UNDER
THE SECURITIES ACT OF 1933
PROUROCARE
MEDICAL INC.
(Exact name of registrant
as specified in its charter)
Nevada
|
|
20-1212923
|
(State or other
jurisdiction of
incorporation)
|
|
(I.R.S. Employer
Identification No.)
|
6440 Flying Cloud Dr., STE 101
Eden Prairie, MN 55344
(Address of Principal
Executive Offices, including zip code)
2009
Stock Plan
(Full title of plan(s))
Richard
C. Carlson, Chief Executive Officer
|
|
Copies
to:
|
6440
Flying Cloud Dr., STE 101
|
|
Timothy
Hearn
|
Eden
Prairie, MN 55344
|
|
Dorsey &
Whitney, LLP
|
(952)
476-9093
|
|
50
South 6
th
Street, Suite 1500
|
(Name, address
and telephone number, including area code, of
agent for service)
|
|
Minneapolis,
MN 55402-1498
(612) 340-7802
|
Indicate by
checkmark whether the registrant is a large accelerated filer, an accelerated
filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated
filer, accelerated filer, and smaller reporting company in Rule 12b-2
of the Exchange Act.
Large accelerated filer
o
|
|
Accelerated
filer
o
|
Non-accelerated filer
o
|
|
Smaller
reporting company
x
|
CALCULATION
OF REGISTRATION FEE
|
|
|
|
|
|
|
|
|
|
Title of securities to be
registered
|
|
Amount to be
registered (1)
|
|
Proposed maximum
offering price per share
(2)
|
|
Proposed maximum
aggregate offering price
(2)
|
|
Amount of
registration fee (2)
|
|
Common stock, $0.00001 par value per share
|
|
1,200,000
|
|
$
|
1.37
|
|
$
|
1,644,000
|
|
$
|
91.74
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
The number of
shares being registered represents the number of shares of the registrants
common stock issuable under the 2009 Stock Plan.
|
|
|
|
Pursuant to
Rule 416 under the Securities Act of 1933, as amended (the Securities
Act), this registration statement also covers any additional shares of
common stock which become issuable under such plans pursuant to their
respective anti-dilution provisions.
|
|
|
(2)
|
Estimated solely for
purposes of computing the registration fee in accordance with
Rule 457(c) and Rule 457(h)(1) under the Securities Act.
The proposed maximum offering price is based upon the average of the closing
bid and asked prices of the registrants common stock as reported on the
Over-the-Counter Bulletin Board on October 13, 2009.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PART II
INFORMATION REQUIRED IN THE REGISTRATION
STATEMENT
Item 3.
Incorporation of Documents by Reference.
The following documents, which have been filed with
the Securities and Exchange Commission (the Commission) by ProUroCare Medical
Inc. (the Company) are incorporated by reference in this registration
statement, as of their respective dates:
(1)
the Companys Annual Report on Form 10-K
for the year ended December 31, 2008 filed with the Commission on March 26,
2009;
(2)
the Companys Quarterly Reports on Form 10-Q
for the quarters ended March 31, 2009 and June 30, 2009 filed with
the Commission on May 14, 2009 and August 14, 2009, respectively;
(3)
the Companys Current Reports on Form 8-K
filed with the Commission on March 25, 2009, May 28, 2009, June 22,
2009, August 5, 2009, August 11, 2009, August 17, 2009, September 22,
2009 and September 28, 2009; and
(4)
the description of the Companys common
stock contained in any registration statement filed by the Company under the
Securities Exchange Act of 1934, as amended (the Exchange Act), including any
amendment or report filed by the Company under the Exchange Act for the purpose
of updating such description.
All documents filed by the Company pursuant to Sections 13(a), 13(c),
14 and 15(d) of the Exchange Act, subsequent to the dates hereof and prior
to the filing of a post-effective amendment which indicates that all securities
offered hereby have been sold or which deregisters all securities remaining
unsold shall be deemed to be incorporated by reference herein and to be a part
hereof from the respective dates of filing of such documents.
Item 4.
Description of Securities.
Not applicable.
Item 5.
Interests of Named Experts and Counsel.
Not applicable.
Item 6.
Indemnification of Officers and Directors.
Pursuant to Article Sixth of the Companys Amended and Restated
Articles of Incorporation, the personal liability of a director of the Company
to the Company or its stockholders for monetary damages for breach of fiduciary
duty as a director shall be eliminated to the fullest extent permitted by law,
as the same exists or may hereafter be amended.
The Company shall indemnify (and advance expenses to) its directors and
officers to the fullest extent permitted by law.
Sections 78.502 and 78.751
of the NRS permit, but do not require, a corporation to indemnify its
directors, officers, employees or agents and expressly provides that the
indemnification provided for under the NRS shall not be deemed exclusive of any
indemnification right under the articles of incorporation, any bylaw, vote of
stockholders or disinterested directors, or otherwise. The NRS permits
indemnification against expenses, including attorneys fees, judgments, fines,
and amount paid in
1
settlement actually and reasonably incurred in
connection with legal actions brought or threatened against such persons for
their conduct on behalf of the corporation, provided that each person acted in
good faith and in a manner that he reasonably believed was in or not opposed to
the corporations best interests and, in the case of a criminal proceeding, had
no reasonable cause to believe his or her conduct was unlawful. To the extent such director, officer,
employee or agent is successful in defense of the action, the NRS provides that
the corporation shall indemnify him against expenses, including attorneys
fees, actually and reasonably incurred by him in connection with the defense.
The NRS does not allow indemnification of directors in the case of an action by
or in the right of the corporation (including stockholder derivative suits)
unless the directors successfully defend the actions or indemnification is
ordered by the court.
Item 7.
Exemption from Registration Claimed.
Not applicable.
Item 8.
Exhibits.
Exhibit No.
|
|
Description
|
|
|
|
4.1
|
|
ProUroCare Medical Inc.
2009 Stock Plan (incorporated by reference to Exhibit 10.1 to Current
Report on Form 8-K filed August 17, 2009)
.
|
|
|
|
5.1
|
|
Opinion
of Dorsey & Whitney, LLP (filed herewith).
|
|
|
|
23.1
|
|
Consent of Baker Tilly
Virchow Krause, LLP (filed herewith)
.
|
|
|
|
23.2
|
|
Consent of
Dorsey & Whitney, LLP
(included in Exhibit 5.1).
|
|
|
|
24.1
|
|
Power of Attorney
(filed herewith)
|
Item 9.
Undertakings.
The undersigned Company hereby undertakes:
·
To file, during any period in which
offers or sales are being made, a post-effective amendment to this registration
statement:
(i) to include any prospectus required by Section 10(a)(3) of
the Securities Act;
(ii) to reflect in the prospectus any facts or
events arising after the effective date of the registration statement (or the
most recent post-effective amendment thereof) which, individually or in the
aggregate, represent a fundamental change in the information set forth in the
registration statement; and
(iii) to include any material information with
respect to the plan of distribution not previously disclosed in the
registration statement or any material change to such information in the
registration statement;
Provided,
however
, That
Paragraphs (a)(1)(i) and
(a)(1)(ii)
of Item 512 of Regulation S-K do
not apply, and the information required
to be included in a post-effective amendment by those paragraphs is contained
in reports filed with or furnished to the Commission by the
2
Company pursuant to
section 13 or section 15(d) of the Exchange Act that are incorporated by
reference in the registration statement;
·
That, for the purpose of determining any
liability under the Securities Act, each such post-effective amendment shall be
deemed to be a new registration statement relating to the securities offered
therein, and the offering of such securities at that time shall be deemed to be
the initial
bona fide
offering thereof;
·
To remove from registration by means of a
post-effective amendment any of the securities being registered which remain
unsold at the termination of the offering;
·
That, for purposes of determining any
liability under the Securities Act, each filing of the Companys annual report
pursuant to Section 13(a) or Section 15(d) of the Exchange
Act that is incorporated by reference in the registration statement shall be
deemed to be a new registration statement relating to the securities offered
therein, and the offering of such securities at that time shall be deemed to be
the initial
bona fide
offering thereof; and
·
Insofar as indemnification for
liabilities arising under the Securities Act may be permitted to directors,
officers and controlling persons of the Company pursuant to the foregoing
provisions, or otherwise, the Company has been advised that in the opinion of
the Commission such indemnification is against public policy as expressed in
the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by the Company of expenses
incurred or paid by a director, officer or controlling person of the Company in
the successful defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the securities being
registered, the Company will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Securities Act and will be governed by the final
adjudication of such issue.
3
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing on Form S-8 and has duly caused this
registration statement to be signed on its behalf by the undersigned, thereunto
duly authorized in the City of Eden Prairie, State of Minnesota, on October 16,
2009.
|
PROUROCARE
MEDICAL INC.
|
|
|
|
|
|
/s/ Richard C. Carlson
|
|
Richard C.
Carlson Chief Executive Officer
|
|
(principal
executive officer)
|
|
|
|
|
|
/s/ Richard Thon
|
|
Richard Thon,
Chief Financial Officer
|
|
(principal
financial officer)
|
Pursuant to the requirements of the Securities Act, this registration
statement has been signed below on October 16, 2009 by the following
persons in the capacities indicated.
Name
|
|
Title
|
|
|
|
|
|
|
/s/ Richard C.
Carson
|
|
Chairman and
Chief Executive Officer
|
Richard c.
Carlson
|
|
|
|
|
|
|
|
|
/s/ David
Koenig*
|
|
Director
|
David Koenig
|
|
|
|
|
|
|
|
|
/s/ Robert
Rudelius*
|
|
Director
|
Robert Rudelius
|
|
|
|
|
|
|
|
|
/s/ Scott Smith*
|
|
Director
|
Scott Smith
|
|
|
*Executed this 16th day of October, 2009, on behalf of the indicated
directors by Richard Thon, duly appointed attorney-in-fact.
By
|
/s/ Richard Thon
|
|
Attorney-in-fact
|
|
4
INDEX TO
EXHIBITS
Exhibit No.
|
|
Description
|
|
|
|
4.1
|
|
ProUroCare Medical Inc.
2009 Stock Plan (incorporated by reference to Exhibit 10.1 to Current
Report on Form 8-K filed August 17, 2009)
.
|
|
|
|
5.1
|
|
Opinion
of Dorsey & Whitney, LLP (filed herewith).
|
|
|
|
23.1
|
|
Consent of Baker Tilly
Virchow Krause, LLP (filed herewith)
.
|
|
|
|
23.2
|
|
Consent of
Dorsey & Whitney, LLP
(included in Exhibit 5.1).
|
|
|
|
24.1
|
|
Power of Attorney
(filed herewith)
|
5
ProUroCare Medical (CE) (USOTC:PUMD)
Historical Stock Chart
From Jun 2024 to Jul 2024
ProUroCare Medical (CE) (USOTC:PUMD)
Historical Stock Chart
From Jul 2023 to Jul 2024